<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235741</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32200</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet A</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. A</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part A</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4825</issn>
<issn pub-type="epub">1552-4833</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30908866</article-id>
<article-id pub-id-type="pmc">6488427</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.a.61112</article-id>
<article-id pub-id-type="manuscript">NIHMS1015946</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>From Process to Progress – 2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ferner</surname>
<given-names>RE</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bakker</surname>
<given-names>A</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elgersma</surname>
<given-names>Y</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Evans</surname>
<given-names>DGR</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giovannini</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Legius</surname>
<given-names>E</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lloyd</surname>
<given-names>A</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Messiaen</surname>
<given-names>LM</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Plotkin</surname>
<given-names>S</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reilly</surname>
<given-names>KM</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schindeler</surname>
<given-names>A</given-names>
</name>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ullrich</surname>
<given-names>NJ</given-names>
</name>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Widemann</surname>
<given-names>B</given-names>
</name>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sherman</surname>
<given-names>LS</given-names>
</name>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Neurofibromatosis Centre, Department of Neurology Guy’s and St. Thomas’ NHS Foundation Trust, and King’s College London, UK</aff>
<aff id="A2"><label>2</label>Children’s Tumor Foundation, New York, New York, USA</aff>
<aff id="A3"><label>3</label>Department of Neuroscience, Erasmus Medical Center, Rotterdam, The Netherlands</aff>
<aff id="A4"><label>4</label>Centre for Genomic Medicine, St. Mary’s Hospital, Manchester, Manchester Academic Health Sciences Centre (MAHSC), Division of Evolution and Genomic Science, University of Manchester, UK</aff>
<aff id="A5"><label>5</label>Department of Head and Neck Surgery, University of California, Los Angeles, USA</aff>
<aff id="A6"><label>6</label>Department of Human Genetics, University Hospital Leuven, Belgium</aff>
<aff id="A7"><label>7</label>Laboratory for Molecular Cell Biology, University College London, UK</aff>
<aff id="A8"><label>8</label>Medical Genomics Laboratory, Department of Genetics, University of Alabama, Birmingham, Alabama, USA</aff>
<aff id="A9"><label>9</label>Department of Neurology and Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA</aff>
<aff id="A10"><label>10</label>Rare Tumors Initiative, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA</aff>
<aff id="A11"><label>11</label>Orthopaedic Research &amp; Biotechnology, The Children’s Hospital at Westmead, Westmead, New South Wales, Australia</aff>
<aff id="A12"><label>12</label>Department of Neurology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA</aff>
<aff id="A13"><label>13</label>Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA</aff>
<aff id="A14"><label>14</label>Division of Neuroscience, Oregon National Primate Research Center, and Department of Cell, Developmental and Cancer Biology, Oregon Health &amp; Science University, Portland, Oregon USA</aff>
<author-notes>
<corresp id="CR1">Correspondence to: Sherman LS, Division of Neuroscience, Oregon National Primate Research Center, 505 NW 185<sup>th</sup> Avenue, Beaverton, OR 97006. Tel: 503-346-5490; Fax: 503-346-5513; <email>shermanl@ohsu.edu</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P53">CONFLICT OF INTEREST</p>
<p id="P54">The authors declare they have no conflicts of interest</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2020</year>
</pub-date>
<volume>179</volume>
<issue>6</issue>
<fpage>1098</fpage>
<lpage>1106</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.a.61112-->
<abstract id="ABS1">
<p id="P1">The neurofibromatoses are inherited, tumor suppressor disorders that are characterized by multiple, benign peripheral nerve sheath tumors and other nervous system tumors. Each disease is associated with a distinct genetic mutation and with a different pathogenesis and clinical course. Neurofibromatosis 1 (NF1) is common and epitomized by multiple neurofibromas with widespread complications. NF2 and schwannomatosis are rare diseases that are typified by multiple schwannomas that are particularly painful in people with schwannomatosis. Since 1985, the Children’s Tumor Foundation has hosted an international Neurofibromatosis Conference, bringing together international participants who are focused on NF research and clinical care. The 2017 Conference, held in Washington DC, was among the largest gatherings of NF researchers to date and included presentations from clinicians and basic scientists, highlighting new data regarding the molecular and cellular mechanisms underlying each of these diseases as well as results from clinical studies and clinical trials. This article summarizes the findings presented at the meeting and represents the current state-of-the art for NF research.</p>
</abstract>
<kwd-group>
<kwd>neurofibromatosis 1</kwd>
<kwd>neurofibromatosis 2</kwd>
<kwd>schwannomatosis</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>